149 related articles for article (PubMed ID: 38323276)
1. A prognostic metabolism-related gene signature associated with the tumor immune microenvironment in neuroblastoma.
Yu X; Xu C; Zou Y; Liu W; Xie Y; Wu C
Am J Cancer Res; 2024; 14(1):253-273. PubMed ID: 38323276
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a novel stemness-related prognostic model for neuroblastoma using integrated machine learning and bioinformatics analyses.
Xia Y; Wang C; Li X; Gao M; Hogg HDJ; Tunthanathip T; Hulsen T; Tian X; Zhao Q
Transl Pediatr; 2024 Jan; 13(1):91-109. PubMed ID: 38323183
[TBL] [Abstract][Full Text] [Related]
3. Integration of clinical characteristics and molecular signatures of the tumor microenvironment to predict the prognosis of neuroblastoma.
Cheng H; Zhang L; Yang S; Ren Q; Chang S; Jin Y; Mou W; Qin H; Yang W; Zhang X; Zhang W; Wang H
J Mol Med (Berl); 2023 Nov; 101(11):1421-1436. PubMed ID: 37712965
[TBL] [Abstract][Full Text] [Related]
4. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma.
Yang T; Luo Y; Liu J; Liu F; Ma Z; Liu G; Li H; Wen J; Chen C; Zeng X
Front Oncol; 2023; 13():1182434. PubMed ID: 37346073
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Signature of Immune Genes and Immune-Related LncRNAs in Neuroblastoma: A Study Based on GEO and TARGET Datasets.
Zhong X; Tao Y; Chang J; Zhang Y; Zhang H; Wang L; Liu Y
Front Oncol; 2021; 11():631546. PubMed ID: 33767996
[TBL] [Abstract][Full Text] [Related]
6. Combined analysis of RNA-sequence and microarray data reveals effective metabolism-based prognostic signature for neuroblastoma.
Meng X; Feng C; Fang E; Feng J; Zhao X
J Cell Mol Med; 2020 Sep; 24(18):10367-10381. PubMed ID: 32683778
[TBL] [Abstract][Full Text] [Related]
7. Construction of a novel anoikis-related prognostic model and analysis of its correlation with infiltration of immune cells in neuroblastoma.
Chen J; Sun M; Chen C; Kang M; Qian B; Sun J; Ma X; Zhou J; Huang L; Jiang B; Fang Y
Front Immunol; 2023; 14():1135617. PubMed ID: 37081871
[TBL] [Abstract][Full Text] [Related]
8. A novel cuproptosis-related gene signature predicting overall survival in pediatric neuroblastoma patients.
Yang H; Yang J; Bian H; Wang X
Front Pediatr; 2022; 10():1049858. PubMed ID: 36568423
[TBL] [Abstract][Full Text] [Related]
9. Identification of Potential Prognostic Genes for Neuroblastoma.
Zhong X; Liu Y; Liu H; Zhang Y; Wang L; Zhang H
Front Genet; 2018; 9():589. PubMed ID: 30555514
[No Abstract] [Full Text] [Related]
10. Ferroptosis-related gene signatures in neuroblastoma associated with prognosis.
Chen Y; Li Z; Cao Q; Guan H; Mao L; Zhao M
Front Cell Dev Biol; 2022; 10():871512. PubMed ID: 36147739
[No Abstract] [Full Text] [Related]
11. An autophagy-related four-lncRNA signature helps to predict progression-free survival of neuroblastoma patients.
Wang J; Meng X; Chen K; Feng J
Front Oncol; 2022; 12():1014845. PubMed ID: 36530992
[TBL] [Abstract][Full Text] [Related]
12. A signature of 29 immune-related genes pairs to predict prognosis in patients with neuroblastoma.
Song J; Zhao Q; Xu Y; Zhu L
Int Immunopharmacol; 2020 Nov; 88():106994. PubMed ID: 33182060
[TBL] [Abstract][Full Text] [Related]
13. GDPD5 Related to Lipid Metabolism Is a Potential Prognostic Biomarker in Neuroblastoma.
Luo T; Peng J; Li Q; Zhang Y; Huang Y; Xu L; Yang G; Tan D; Zhang Q; Tan Y
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430219
[TBL] [Abstract][Full Text] [Related]
14. Characterizing the key genes of COVID-19 that regulate tumor immune microenvironment and prognosis in hepatocellular carcinoma.
Gao S; Zhang L; Wang H
Funct Integr Genomics; 2023 Aug; 23(3):262. PubMed ID: 37540264
[TBL] [Abstract][Full Text] [Related]
15. Prognosis analysis and validation of lipid metabolism-associated lncRNAs and tumor immune microenvironment in bladder cancer.
Tan Z; Fu S; Zuo J; Wang J; Wang H
Aging (Albany NY); 2023 Aug; 15(16):8384-8407. PubMed ID: 37632832
[TBL] [Abstract][Full Text] [Related]
16. Novel amino acid metabolism-related gene signature to predict prognosis in clear cell renal cell carcinoma.
Cheng X; Deng W; Zhang Z; Zeng Z; Liu Y; Zhou X; Zhang C; Wang G
Front Genet; 2022; 13():982162. PubMed ID: 36118874
[No Abstract] [Full Text] [Related]
17. Identification of hub genes and their correlation with infiltration of immune cells in
Chen J; Sun M; Chen C; Jiang B; Fang Y
Front Immunol; 2022; 13():1016683. PubMed ID: 36311753
[TBL] [Abstract][Full Text] [Related]
18. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
[TBL] [Abstract][Full Text] [Related]
19. Characterization and application of a lactate and branched chain amino acid metabolism related gene signature in a prognosis risk model for multiple myeloma.
Yu Z; Qiu B; Zhou H; Li L; Niu T
Cancer Cell Int; 2023 Aug; 23(1):169. PubMed ID: 37580667
[TBL] [Abstract][Full Text] [Related]
20. Identification and Characterization of a Glucometabolic Prognostic Gene Signature in Neuroblastoma based on N6-methyladenosine Eraser ALKBH5.
Tan K; Wu W; Zhu K; Lu L; Lv Z
J Cancer; 2022; 13(7):2105-2125. PubMed ID: 35517412
[No Abstract] [Full Text] [Related]
[Next] [New Search]
